Deal Making

Featured on Deal Making

Hemophilia A-OK! FTC thumbs up effectively closes Roche’s $4.3bn Spark buy
Regulations
Hemophilia A-OK! FTC thumbs up effectively closes Roche’s $4.3bn Spark buyHemophilia A-OK! FTC thumbs up effectively closes Roche’s $4.3bn Spark buy

There is no risk of competitive harm between Roche’s approved hemophila A monoclonal antibody and Spark’s gene therapy candidates, say competition bodies.

byDan Stanton
Dec 17, 2019
|
2 Min Read
Charles River bids $380m to buy cell therapy services firm HemaCare
Deal-Making
Charles River bids $380m to buy cell therapy services firm HemaCareCharles River bids $380m to buy cell therapy services firm HemaCare
byGareth Macdonald
Dec 17, 2019
2 Min Read
Sanofi wins US HHS $226m contract to expand PA vaccine capacity
Bioprocess Insider
Sanofi wins US HHS $226m contract to expand PA vaccine capacitySanofi wins US HHS $226m contract to expand PA vaccine capacity
byGareth Macdonald
Dec 12, 2019
2 Min Read
AI will help Novartis make personalized meds, says Amazon
Deal-Making
AI will help Novartis make personalized meds, says AmazonAI will help Novartis make personalized meds, says Amazon
byGareth Macdonald
Dec 10, 2019
2 Min Read
Zelluna and Glycostem team on natural killer TCRs for solid tumors
Deal-Making
Zelluna and Glycostem team on natural killer TCRs for solid tumorsZelluna and Glycostem team on natural killer TCRs for solid tumors
byGareth Macdonald
Dec 5, 2019
2 Min Read
Astellas: Large-scale gene therapy plant major driver in $3bn Audentes deal
Deal-Making
Astellas: Large-scale gene therapy plant major driver in $3bn Audentes dealAstellas: Large-scale gene therapy plant major driver in $3bn Audentes deal
byDan Stanton
Dec 4, 2019
2 Min Read

More from Deal Making

Blame the messenger: Novartis cites RNAi candidate in $9.7bn Medicines Company deal
Deal-Making
Blame the messenger: Novartis cites RNAi candidate in $9.7bn Medicines Company deal
Blame the messenger: Novartis cites RNAi candidate in $9.7bn Medicines Company deal
Nov 26, 2019
|
2 Min Read
byGareth Macdonald
WuXi on board for Tychan’s yellow fever mAb
Deal-Making
WuXi on board for Tychan’s yellow fever mAb
WuXi on board for Tychan’s yellow fever mAb
Nov 20, 2019
|
2 Min Read
byGareth Macdonald
Biolife buys CBS, turns focus on integrating cold-chain acquisitions
Deal-Making
Biolife buys CBS, turns focus on integrating cold-chain acquisitions
Biolife buys CBS, turns focus on integrating cold-chain acquisitions
Nov 15, 2019
|
3 Min Read
byGareth Macdonald
Horizon Discovery divests animal model biz to focus on cell lines
Deal-Making
Horizon Discovery divests animal model biz to focus on cell lines
Horizon Discovery divests animal model biz to focus on cell lines
Nov 13, 2019
|
2 Min Read
byDan Stanton
Mesa Labs picks up Gyros in $180m bio QC deal
Deal-Making
Mesa Labs picks up Gyros in $180m bio QC deal
Mesa Labs picks up Gyros in $180m bio QC deal
Nov 11, 2019
|
2 Min Read
byBPI Staff
Aspen alert! Novartis buys assets for $330m in Japan boost
Global Markets
Aspen alert! Novartis buys assets for $330m in Japan boost
Aspen alert! Novartis buys assets for $330m in Japan boost
Nov 11, 2019
|
1 Min Read
byBPI Staff
Cognate buys Cobra to boost gene therapy CDMO capabilities
Deal-Making
Cognate buys Cobra to boost gene therapy CDMO capabilities
Cognate buys Cobra to boost gene therapy CDMO capabilities
Nov 6, 2019
|
2 Min Read
byBPI Staff
LBPs for gene therapies: Thermo Fisher inks deal with another Bamforth biz
Deal-Making
LBPs for gene therapies: Thermo Fisher inks deal with another Bamforth biz
LBPs for gene therapies: Thermo Fisher inks deal with another Bamforth biz
Nov 6, 2019
|
2 Min Read
byDan Stanton
Amgen takes $2.7bn stake in BeiGene to up presence in China
Global Markets
Amgen takes $2.7bn stake in BeiGene to up presence in China
Amgen takes $2.7bn stake in BeiGene to up presence in China
Nov 1, 2019
|
3 Min Read
byDan Stanton
Avacta teams with ADC Therapeutics on Affimer conjugates
Therapeutic Class
Avacta teams with ADC Therapeutics on Affimer conjugates
Avacta teams with ADC Therapeutics on Affimer conjugates
Nov 1, 2019
|
3 Min Read
byGareth Macdonald
Cesca and HealthBanks jump on the CAR-TXpress in cell banking JV
Deal-Making
Cesca and HealthBanks jump on the CAR-TXpress in cell banking JV
Cesca and HealthBanks jump on the CAR-TXpress in cell banking JV
Oct 30, 2019
|
2 Min Read
byGareth Macdonald
Chinese CMC: CMAB to make bi-functional antibody for BJ
Deal-Making
Chinese CMC: CMAB to make bi-functional antibody for BJ
Chinese CMC: CMAB to make bi-functional antibody for BJ
Oct 22, 2019
|
2 Min Read
byGareth Macdonald
Danaher offloads assets to Sartorius for $750m; GE buy pushed back to 2020
Upstream & Downstream Processing
Danaher offloads assets to Sartorius for $750m; GE buy pushed back to 2020
Danaher offloads assets to Sartorius for $750m; GE buy pushed back to 2020
Oct 21, 2019
|
2 Min Read
byDan Stanton
Combigene teams with Cobra and NBR on epilepsy gene therapy
Deal-Making
Combigene teams with Cobra and NBR on epilepsy gene therapy
Combigene teams with Cobra and NBR on epilepsy gene therapy
Oct 18, 2019
|
2 Min Read
byDan Stanton
Big M&A: Alexion in $930m Achillion buy, UCB bids $2.1bn for Ra
Deal-Making
Big M&A: Alexion in $930m Achillion buy, UCB bids $2.1bn for Ra
Big M&A: Alexion in $930m Achillion buy, UCB bids $2.1bn for Ra
Oct 16, 2019
|
3 Min Read
byBPI Staff
CDMO focus: Strategic gene therapy deals and $250m sell-off
Deal-Making
CDMO focus: Strategic gene therapy deals and $250m sell-off
CDMO focus: Strategic gene therapy deals and $250m sell-off
Oct 9, 2019
|
3 Min Read
byBPI Staff
Cellectis selects Lonza for off-the-shelf CAR-T manufacture
Deal-Making
Cellectis selects Lonza for off-the-shelf CAR-T manufacture
Cellectis selects Lonza for off-the-shelf CAR-T manufacture
Oct 4, 2019
|
2 Min Read
byBPI Staff
BWB startup pitch: Biopharm America's got talent
Deal-Making
BWB startup pitch: Biopharm America's got talent
BWB startup pitch: Biopharm America's got talent
Sep 17, 2019
|
2 Min Read
byDan Stanton, BPI Staff
Lundbeck adding migraine ‘blockbuster’ and Ab capabilities in $2bn Alder buy
Deal-Making
Lundbeck adding migraine ‘blockbuster’ and Ab capabilities in $2bn Alder buy
Lundbeck adding migraine ‘blockbuster’ and Ab capabilities in $2bn Alder buy
Sep 17, 2019
|
2 Min Read
byDan Stanton
Lonza to make ‘NET’ antibody for Citryll
Deal-Making
Lonza to make ‘NET’ antibody for Citryll
Lonza to make ‘NET’ antibody for Citryll
Sep 13, 2019
|
2 Min Read
byBPI Staff
MilliporeSigma buys data platform to bolster its Biopharma 4.0 offering
Upstream & Downstream Processing
MilliporeSigma buys data platform to bolster its Biopharma 4.0 offering
MilliporeSigma buys data platform to bolster its Biopharma 4.0 offering
Sep 6, 2019
|
2 Min Read
byDan Stanton
Vertex looks to stem cell islets for diabetes in $950m ‘toolbox’ deal
Deal-Making
Vertex looks to stem cell islets for diabetes in $950m ‘toolbox’ deal
Vertex looks to stem cell islets for diabetes in $950m ‘toolbox’ deal
Sep 4, 2019
|
3 Min Read
byDan Stanton
Batavia selects CHO platform for Zika Ab on the Horizon
Deal-Making
Batavia selects CHO platform for Zika Ab on the Horizon
Batavia selects CHO platform for Zika Ab on the Horizon
Sep 4, 2019
|
1 Min Read
byBPI Staff
Novartis to take on Biogen with Tysabri biosimilar pact
Global Markets
Novartis to take on Biogen with Tysabri biosimilar pact
Novartis to take on Biogen with Tysabri biosimilar pact
Sep 3, 2019
|
1 Min Read
byDan Stanton
Not all about that base: Catalent organic downside offset by M&A
Deal-Making
Not all about that base: Catalent organic downside offset by M&A
Not all about that base: Catalent organic downside offset by M&A
Sep 2, 2019
|
3 Min Read
byDan Stanton
Dyadic: Deals stack up as industry looks to ‘game-changing’ expression system
Deal-Making
Dyadic: Deals stack up as industry looks to ‘game-changing’ expression system
Dyadic: Deals stack up as industry looks to ‘game-changing’ expression system
Aug 16, 2019
|
2 Min Read
byDan Stanton
CMOs to continue picking up Big Pharma non-core facilities
Facilities & Capacity
CMOs to continue picking up Big Pharma non-core facilities
CMOs to continue picking up Big Pharma non-core facilities
Aug 14, 2019
|
2 Min Read
byDan Stanton
AskBio buys Synpromics, plans expansion
Deal-Making
AskBio buys Synpromics, plans expansion
AskBio buys Synpromics, plans expansion
Aug 13, 2019
|
1 Min Read
byBPI Staff
Lonza to simplify vein-to-vein supply chain with Vineti partnership
Therapeutic Class
Lonza to simplify vein-to-vein supply chain with Vineti partnership
Lonza to simplify vein-to-vein supply chain with Vineti partnership
Aug 13, 2019
|
2 Min Read
byDan Stanton
Pfizer licenses AAV platform for ataxia gene therapy
Deal-Making
Pfizer licenses AAV platform for ataxia gene therapy
Pfizer licenses AAV platform for ataxia gene therapy
Aug 9, 2019
|
1 Min Read
byBPI Staff

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Ask the Expert webcasts
ATE Webcasts
Register Now: Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System
Register Now: Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System
Ask the Expert webcasts
ATE Webcasts
Register Now: Out of the Box Computer Software Assurance with ValGenesis VLMS
Register Now: Out of the Box Computer Software Assurance with ValGenesis VLMS
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Repligen white paper
Sponsored Content
30% Increase in Concentration Accuracies with KrosFlo® RS 30 RPM™ TFF System
30% Increase in Concentration Accuracies with KrosFlo® RS 30 RPM™ TFF System

Oct 25, 2024

Solventum white paper
Sponsored Content
3M™ Harvest RC Centrate Chromatographic Clarifier: Evolving the Role of Clarification in the Biopharmaceutical Manufacturing Process
3M™ Harvest RC Centrate Chromatographic Clarifier: Evolving the Role of Clarification in the Biopharmaceutical Manufacturing Process

Oct 25, 2024

Tosoh AEX Method
Sponsored Content
Improved Safety in Ion Exchange Chromatography for Empty/Full Adeno-Associated Virus Analysis
Improved Safety in Ion Exchange Chromatography for Empty/Full Adeno-Associated Virus Analysis

Oct 14, 2024